Back
Travere Therapeutics Stock Predictions
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!
Sell
29
TVTX
Travere Therapeutics
Last Price:
6.2600
Seasonality Move:
-0.72%
7 Day Trial
ALL ACCESS PASS
$
7
Elon's Secret "A.I. 2.0" Project
Click here now to discover how to claim a stake in Elon's "A.I. 2.0" projectTravere Therapeutics Stock Forecast
- Over the next 52 weeks, Travere Therapeutics has on average historically fallen by 5.5% based on the past 14 years of stock performance.
- Travere Therapeutics has fallen lower in 8 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
-
Is Travere Therapeutics Stock Undervalued?
The current Travere Therapeutics [TVTX] share price is $6.2600. The Score for TVTX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal. - TVTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Travere Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Travere Therapeutics has on average historically fallen by 5.5% based on the past 14 years of stock performance.
Travere Therapeutics Stock Rating
Sell
29
Travere Therapeutics (TVTX)
is a Sell
Is Travere Therapeutics overpriced?
- Travere Therapeutics has fallen lower in 8 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
Travere Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
travere.com
52-Week Data
52-Week High:
19.5424
52-Week Low:
5.1200
Prediction Charts
Market Cap:
476.38M
Price in USD:
6.2600
Volume:
767.08K
Beta:
55.6159
Technical Analysis
SMA50:
7.0712
SMA100:
7.9459
SMA200:
9.1660
52-Wk Change:
-60.65%
Stock Predictions
-
Is Travere Therapeutics stock public?
Yes, Travere Therapeutics is a publicly traded company. -
What is the Travere Therapeutics stock quote today?
The Travere Therapeutics stock price is 6.2600 USD today. -
How to buy Travere Therapeutics stock online?
You can buy Travere Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-16 | 6.2300 | 6.1500 | 6.3600 | 6.1128 |
| Apr-17 | 6.2400 | 5.9900 | 6.3400 | 5.9400 |
| Apr-18 | 5.9700 | 5.8000 | 6.0200 | 5.7750 |
| Apr-19 | 5.7300 | 5.7200 | 5.9100 | 5.5750 |
| Apr-22 | 5.7700 | 5.8500 | 5.9350 | 5.7050 |
| Apr-23 | 5.8500 | 5.7400 | 5.9600 | 5.7100 |
| Apr-24 | 5.7800 | 5.4500 | 5.7800 | 5.3400 |
| Apr-25 | 5.5000 | 5.3900 | 5.5000 | 5.1200 |
| Apr-26 | 5.4000 | 5.2600 | 5.5550 | 5.2100 |
| Apr-29 | 5.3300 | 5.4600 | 5.5650 | 5.2350 |
| Apr-30 | 5.3800 | 5.5200 | 5.7600 | 5.3000 |
| May-1 | 5.5400 | 5.9800 | 6.1100 | 5.5400 |
| May-2 | 6.0900 | 6.1600 | 6.2050 | 5.7900 |
| May-3 | 6.4400 | 6.2600 | 6.5600 | 6.1800 |
Travere Therapeutics Earnings
Travere Therapeutics Earnings Report: Per Share Travere Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Travere Therapeutics Forecast Revenue Growth
Travere Therapeutics Stock Analysis: Historical quarterly revenues per share for Travere Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.56 per share, an increase next quarter of $0.07 per share, a decrease this year of $1.65 per share, and an increase next year of $1.32 per share.
* Travere Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.